Verrica Pharmaceuticals Stock
Price
Target price
-
-
-
-
-
?14.48
WKN: A2JPEV / Symbol: VRCA / Name: Verrica Pharmaceuticals / Stock / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Verrica Pharmaceuticals Stock
The community is currently still undecided about Verrica Pharmaceuticals with 1 Buy predictions and 0 Sell predictions.
With a target price of 14 € there is potential for a 2309.64% increase which would mean more than doubling the current price of 0.58 € for Verrica Pharmaceuticals.
Our community identified positive and negative aspects for Verrica Pharmaceuticals stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Verrica Pharmaceuticals stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Verrica Pharmaceuticals in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at Brookline Capital Management from a "hold" rating to a "buy" rating. They now have a $17.00 price target on the stock.
Show more
Ratings data for VRCA provided by MarketBeat
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target lowered by analysts at TD Cowen from $15.00 to $10.00. They now have a "buy" rating on the stock.
Show more
Ratings data for VRCA provided by MarketBeat
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target lowered by analysts at Royal Bank of Canada from $13.00 to $11.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for VRCA provided by MarketBeat